Top story
This Brain Implant Says F*** Your Eyeballs, Goes Straight to the Source
ICVP brain implant skips your eyes entirely and wires directly into the visual cortex. Third patient just got one. The age of biological middleware bypass is here.
CRISPR Just Went Predator Mode on Cancer Cells
USU researchers just proved CRISPR-Cas12a2 can hunt and destroy cancer cells while sparing healthy tissue — 50% tumor reduction in mice from a single dose. The biohacking crowd is about to lose it.
Your 2021 AI Art Is Nostalgia Bait Now. Feel Old Yet?
Someone posted their 2021 AI art on Reddit like it's a vintage find. In AI years, it basically is. From DALL-E's blobby nightmares to today's photoreal slop — a eulogy for when AI felt like magic.
Sony's $3.6B Bungie Bet Bleeds Hundreds of Millions on Marathon
Sony admits Bungie's Marathon reboot burned hundreds of millions after that $3.6B acquisition. Live-service dreams meet extraction shooter nightmares.
Elon Rents GPUs to Claude: AI's Desperate Compute Shuffle
Elon Musk's xAI rents GPUs to Anthropic's Claude amid compute crunch, sparking weird alliances, intelligence drops, and a rush to local AI rigs. Hype's turning to hustle.
Self-Destructing Plastic Exists Now and It's Peak Irony
Scientists made plastic with embedded bacteria that self-destructs on command. Cool science, but we're still hoarding Stanley cups and fighting over limited sneaker drops like the world isn't drowning in microplastics.
RIP Ask Jeeves: The Original AI Butler Dies at 30
Ask.com is dead. The OG 'natural language' search engine that predated ChatGPT by 25 years finally flatlined — proving that being right too early is the same as being wrong.
Sora 2 Launch: Indie Tools Hijack the AI Video Hype Train
Sora 2's impending launch is igniting AI video gen, but indie tools like ImagineToVideo and Seedance 2.0 are already stealing the spotlight with accessible, hype-fueled creation—no Big Tech wait required.
Biotech 2026: AI Brochure Promised Cures, Lab Got Chatbots
The AI-biotech hype cycle promised miracle drugs by 2026. Labs got chatbots, hallucinated drug targets, and pressure to 'integrate ML' into everything. Zero AI-designed drugs approved. The grift meets reality.
The Juicero Squeeze: When Silicon Valley Juiced Investors
The $700 juicer that could be out-squeezed by human hands — Juicero's spectacular flameout is the ultimate cautionary tale of Silicon Valley hype.